PRASAD SUYASH
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to PRASAD SUYASH. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TSHA | CMO and Head of R&D | Sale | 8,956 | $3.79 | $33,943 | Jul 5, 2022 |
| TSHA | CMO and Head of R&D | Sale | 12,324 | $3.81 | $46,954 | Jun 30, 2022 |
| TSHA | CMO and Head of R&D | Sale | 300 | $25.19 | $7,557 | Jun 29, 2021 |
| TSHA | CMO and Head of R&D | C | 3,844 | — | — | Sep 28, 2020 |
| TSHA | CMO and Head of R&D | Award / Grant | 668,745 | — | — | Sep 23, 2020 |
| 0001628738 | Senior VP & Chief Med Officer | Tax Withholding | 757 | $37.31 | $28,244 | Jun 5, 2019 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 54 | $37.72 | $2,037 | May 13, 2019 |
| 0001628738 | Senior VP & Chief Med Officer | Option Exercise | 10,000 | $0.79 | $7,900 | Feb 25, 2019 |
| 0001628738 | Senior VP & Chief Med Officer | Award / Grant | 17,500 | — | — | Feb 6, 2019 |
| 0001628738 | Senior VP & Chief Med Officer | Award / Grant | 736 | $19.64 | $14,455 | Nov 15, 2018 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 200 | $36.32 | $7,264 | Oct 1, 2018 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 4,989 | $38.02 | $189,682 | Jul 2, 2018 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 7,800 | $30.03 | $234,234 | Mar 29, 2018 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 1,900 | $30.00 | $57,000 | Mar 26, 2018 |
| 0001628738 | Senior VP & Chief Med Officer | Option Exercise | 6,770 | $0.79 | $5,348 | Dec 1, 2017 |
| 0001628738 | Senior VP & Chief Med Officer | Sale | 8,000 | $21.44 | $171,520 | Sep 1, 2017 |